SolEmuls® Technology: A Way to Overcome the Drawback of Parenteral Administration of Insoluble Drugs

Author： Junghanns J. -U.   Buttle I.   Müller R. H.   Araújo I. B.   Silva A. K. A.   Egito E. S. T.   Damasceno B. P. G. L.  

Publisher： Informa Healthcare

ISSN： 1083-7450

Source： Pharmaceutical Development and Technology, Vol.12, Iss.5, 2007-09, pp. : 437-445

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous itraconazole emulsions produced by SolEmuls technology

By Akkar A.   Muller R.H.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 56, Iss. 1, 2003-07 ,pp. : 29-36

Elsevier

Access to resources Recommend Favorite

SolEmuls ( R)-novel technology for the formulation of i.v. emulsions with poorly soluble drugs

By Muller R.H.   Schmidt S.   Buttle I.   Akkar A.   Schmitt J.   Bromer S.  

International Journal of Pharmaceutics, Vol. 269, Iss. 2, 2004-01 ,pp. : 293-302

Elsevier

Access to resources Recommend Favorite

Pharmacology of Drugs Formulated with DepoFoam™: A Sustained Release Drug Delivery System for Parenteral Administration Using Multivesicular Liposome Technology

By Angst Martin S.   Drover David R.  

Clinical Pharmacokinetics, Vol. 45, Iss. 12, 2006-01 ,pp. : 1153-1176

Adis International

Access to resources Recommend Favorite

Nanocrystals Technology for Transdermal Delivery of Water-Insoluble Drugs

By  

Current Drug Delivery, Vol. 15, Iss. 9, 2018-11 ,pp. : 1221-1229

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Characteristics of Parenteral IGF-I Administration

By  

Current Pharmaceutical Biotechnology, Vol. 4, Iss. 2, 2003-04 ,pp. : 123-140

Bentham Science Publishers

Access to resources Recommend Favorite